方舟生物医药(ABIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABIO 方舟生物医药

休市中 05-17 16:00:00 EDT

3.33

-0.67

-16.75%

盘后3.43

+0.10+3.00%

19:46 EDT

最高4.49	最低3.11	成交量45.74万
今开4.09	昨收4.00	日振幅34.50%
总市值4,831万	流通市值1,641万	总股本1,451万
成交额169.20万	换手率9.28%	流通股本492.67万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABIO","market":"US","secType":"STK","nameCN":"方舟生物医药","latestPrice":3.33,"timestamp":1715976000000,"preClose":4,"halted":0,"volume":457396,"hourTrading":{"tag":"盘后","latestPrice":3.43,"preClose":3.33,"latestTime":"19:46 EDT","volume":5668,"amount":18997.1303,"timestamp":1715989600643},"delay":0,"floatShares":4926721,"shares":14507143,"eps":-0.41569,"marketStatus":"休市中","marketStatusCode":7,"change":-0.67,"latestTime":"05-17 16:00:00 EDT","open":4.09,"high":4.49,"low":3.11,"amount":1691988.0312584,"amplitude":0.345,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.41569,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":871012800000,"adjPreClose":4,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.12,"preClose":4,"latestTime":"09:06 EDT","volume":1789,"amount":7324.566736,"timestamp":1715951197953},"postHourTrading":{"tag":"盘后","latestPrice":3.43,"preClose":3.33,"latestTime":"19:46 EDT","volume":5668,"amount":18997.1303,"timestamp":1715989600643},"volumeRatio":3.349582300605341},"requestUrl":"/m/hq/s/ABIO","defaultTab":"news","newsList":[{"id":"2435541092","title":"方舟生物医药盘中异动 股价大跌5.00%报3.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435541092","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435541092?lang=zh_cn&edition=full","pubTime":"2024-05-15 01:50","pubTimestamp":1715709004,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日01时50分，方舟生物医药股票出现异动，股价大幅下跌5.00%。截至发稿，该股报3.23美元/股，成交量4.4649万股，换手率0.31%，振幅7.48%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.09%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240515015005861ed24b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240515015005861ed24b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435378229","title":"方舟生物医药盘中异动 股价大跌9.57%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435378229","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435378229?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:30","pubTimestamp":1715607044,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时30分，方舟生物医药股票出现波动，股价急速下跌9.57%。截至发稿，该股报3.14美元/股，成交量1.5071万股，换手率0.10%，振幅9.80%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.00%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213044861eccb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213044861eccb3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434852835","title":"方舟生物医药盘中异动 早盘急速拉升5.28%报3.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434852835","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434852835?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:00","pubTimestamp":1715349620,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日22时00分，方舟生物医药股票出现异动，股价快速上涨5.28%。截至发稿，该股报3.55美元/股，成交量1.572万股，换手率0.11%，振幅4.74%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.40%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102200217a5941bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102200217a5941bd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432797086","title":"方舟生物医药盘中异动 早盘股价大涨6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432797086","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432797086?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:33","pubTimestamp":1714743206,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时33分，方舟生物医药股票出现波动，股价快速上涨6.13%。截至发稿，该股报3.46美元/股，成交量1376股，换手率0.01%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032133267925c0c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032133267925c0c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432687208","title":"方舟生物医药盘中异动 下午盘快速跳水5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432687208","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432687208?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:17","pubTimestamp":1714587463,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时17分，方舟生物医药股票出现异动，股价大幅跳水5.73%。截至发稿，该股报3.29美元/股，成交量4.2484万股，换手率0.29%，振幅6.02%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为1.31%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020217447a57df05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020217447a57df05&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430027065","title":"方舟生物医药盘中异动 快速拉升5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430027065","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430027065?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:31","pubTimestamp":1714138292,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日21时31分，方舟生物医药股票出现异动，股价快速拉升5.75%。截至发稿，该股报3.68美元/股，成交量1.0512万股，换手率0.07%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.50%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042621313387b3f094&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042621313387b3f094&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430268389","title":"ARCA biopharma(ABIO.US)：2024年Q1财报实现营收0美元，前值为0美元；每股收益为-0.14美元，前值为-0.09美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2430268389","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430268389?lang=zh_cn&edition=full","pubTime":"2024-04-26 05:55","pubTimestamp":1714082125,"startTime":"0","endTime":"0","summary":"ARCA biopharma(ABIO.US)：2024年Q1财报实现营收0美元，前值为0美元；每股收益为-0.14美元，前值为-0.09美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260555418b5468ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260555418b5468ca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429135751","title":"方舟生物医药盘中异动 股价大涨5.35%报3.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429135751","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429135751?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:07","pubTimestamp":1713881275,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时07分，方舟生物医药股票出现异动，股价快速拉升5.35%。截至发稿，该股报3.63美元/股，成交量2.9783万股，换手率0.21%，振幅3.77%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.34百万美元，每股收益-0.37美元，毛利-111000.00美元，市盈率-9.68倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为1.26%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423220755861e8302&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423220755861e8302&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428635786","title":"方舟生物医药盘中异动 大幅上涨5.08%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428635786","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428635786?lang=zh_cn&edition=full","pubTime":"2024-04-19 22:50","pubTimestamp":1713538207,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日22时50分，方舟生物医药股票出现异动，股价快速上涨5.08%。截至发稿，该股报3.42美元/股，成交量28.0297万股，换手率1.93%，振幅6.15%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.24%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419225008861e77a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419225008861e77a6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426113814","title":"方舟生物医药盘中异动 急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426113814","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426113814?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:28","pubTimestamp":1712672939,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时28分，方舟生物医药股票出现波动，股价大幅拉升5.00%。截至发稿，该股报3.15美元/股，成交量13.4265万股，换手率0.93%，振幅5.55%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.24%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092229007a51a7c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092229007a51a7c1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424451308","title":"方舟生物医药盘中异动 早盘股价大涨69.08%报2.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424451308","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424451308?lang=zh_cn&edition=full","pubTime":"2024-04-03 21:31","pubTimestamp":1712151069,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日21时31分，方舟生物医药股票出现异动，股价快速上涨69.08%。截至发稿，该股报2.89美元/股，成交量909.037万股，换手率62.69%，振幅1.75%。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Kintara Therapeutics, Inc.、方舟生物医药、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Addex Therapeutics Limited较为活跃，换手率分别为225.62%、63.71%、16.06%，振幅较大的相关个股有Kintara Therapeutics, Inc.、居里、康乃德生物，振幅分别为11.65%、9.09%、8.65%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032131098aed9619&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032131098aed9619&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424884833","title":"BUZZ-ARCA 生物制药公司与 Oruka Therapeutics 公司达成合并协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2424884833","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424884833?lang=zh_cn&edition=full","pubTime":"2024-04-03 20:59","pubTimestamp":1712149160,"startTime":"0","endTime":"0","summary":"    4月3日 - ** ARCA生物制药公司  股价盘前大涨约87%至3.2美元** 公司将与私营生物技术公司 Oruka Therapeutics 以全股票交易方式合并** Oruka 获得了由 Fairmount 和 Venrock Healthcare Capital Partners 领导的医疗保健投资者集团提供的 2.75 亿美元股票和认股权证资金，以支持这项交易。** 合并后的新公司将以 Oruka Therapeutics 的名义运营，并在纳斯达克交易，股票代码为 \"ORKA\"。** 截至上一交易日收盘，ABIO 年累计上涨约 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409745182","title":"方舟生物医药盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409745182","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409745182?lang=zh_cn&edition=full","pubTime":"2024-02-08 23:32","pubTimestamp":1707406332,"startTime":"0","endTime":"0","summary":"北京时间2024年02月08日23时32分，方舟生物医药股票出现异动，股价急速拉升5.00%。截至发稿，该股报1.68美元/股，成交量1.5057万股，换手率0.10%，振幅2.19%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.28%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208233212861d4bf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240208233212861d4bf2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406794455","title":"方舟生物医药盘中异动 快速拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406794455","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406794455?lang=zh_cn&edition=full","pubTime":"2024-01-26 23:19","pubTimestamp":1706282385,"startTime":"0","endTime":"0","summary":"北京时间2024年01月26日23时19分，方舟生物医药股票出现异动，股价快速上涨5.34%。截至发稿，该股报1.73美元/股，成交量9403股，换手率0.07%，振幅4.73%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.07%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012623194687e6902e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012623194687e6902e&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcabiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0403},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.994},{"period":"6month","weight":0.8398},{"period":"1year","weight":0.5857},{"period":"ytd","weight":0.9588}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"方舟生物医药公司是一家生物制药公司,该公司主要致力于心血管疾病的基因疗法。公司的领先候选产品是Gencaro TM，一种有效的β受体阻滞剂同时还是温和的血管舒张药，正被开发用于治疗心房纤维颤动患者的心脏衰竭。公司已经识别出在心血管系统中常见的基因变异，并认为这与Gencaro的药理有关，并能预测病人对药物的反应。2009年1月27日，公司根据并购重组条款与ARCA科罗拉多完成业务合并，Nuvelo公司的全资子公司并入ARCA科罗拉多，ARCA科罗拉多州继续作为合并存续公司并成为Nuvelo公司的子公司，合并后，公司从Nuvelo更名为ARCA生物制药公司。Nuvelo最初注册名为Hyseq公司，于1992年在伊利诺伊州注册，并于1993年在内华达州重新注册。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.061348},{"month":2,"riseRate":0.375,"avgChangeRate":-0.063833},{"month":3,"riseRate":0.3125,"avgChangeRate":-0.030249},{"month":4,"riseRate":0.5625,"avgChangeRate":0.101192},{"month":5,"riseRate":0.4375,"avgChangeRate":0.090154},{"month":6,"riseRate":0.2,"avgChangeRate":0.506541},{"month":7,"riseRate":0.533333,"avgChangeRate":0.029407},{"month":8,"riseRate":0.066667,"avgChangeRate":-0.142547},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.075747},{"month":10,"riseRate":0.4,"avgChangeRate":-0.066754},{"month":11,"riseRate":0.666667,"avgChangeRate":0.018484},{"month":12,"riseRate":0.533333,"avgChangeRate":0.003511}],"exchange":"NASDAQ","name":"方舟生物医药","nameEN":"ARCA biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"方舟生物医药(ABIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供方舟生物医药(ABIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"方舟生物医药,ABIO,方舟生物医药股票,方舟生物医药股票老虎,方舟生物医药股票老虎国际,方舟生物医药行情,方舟生物医药股票行情,方舟生物医药股价,方舟生物医药股市,方舟生物医药股票价格,方舟生物医药股票交易,方舟生物医药股票购买,方舟生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"方舟生物医药(ABIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供方舟生物医药(ABIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}